Anika Therapeutics (ANIK) Competitors $11.14 +0.14 (+1.23%) As of 01:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIK vs. ANVS, CERS, OSUR, UTMD, WST, COO, ALGN, MMSI, HAE, and ICUIShould you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include Annovis Bio (ANVS), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), and ICU Medical (ICUI). These companies are all part of the "medical" sector. Anika Therapeutics vs. Its Competitors Annovis Bio Cerus OraSure Technologies Utah Medical Products West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical Anika Therapeutics (NASDAQ:ANIK) and Annovis Bio (NYSE:ANVS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation. Does the media refer more to ANIK or ANVS? In the previous week, Anika Therapeutics had 1 more articles in the media than Annovis Bio. MarketBeat recorded 1 mentions for Anika Therapeutics and 0 mentions for Annovis Bio. Anika Therapeutics' average media sentiment score of 1.87 beat Annovis Bio's score of 0.00 indicating that Anika Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Anika Therapeutics Very Positive Annovis Bio Neutral Do analysts recommend ANIK or ANVS? Anika Therapeutics currently has a consensus target price of $20.00, suggesting a potential upside of 79.61%. Annovis Bio has a consensus target price of $18.00, suggesting a potential upside of 565.43%. Given Annovis Bio's higher probable upside, analysts clearly believe Annovis Bio is more favorable than Anika Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anika Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Annovis Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more risk and volatility, ANIK or ANVS? Anika Therapeutics has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500. Comparatively, Annovis Bio has a beta of 1.57, meaning that its share price is 57% more volatile than the S&P 500. Do institutionals and insiders hold more shares of ANIK or ANVS? 91.5% of Anika Therapeutics shares are held by institutional investors. Comparatively, 15.8% of Annovis Bio shares are held by institutional investors. 9.6% of Anika Therapeutics shares are held by insiders. Comparatively, 20.8% of Annovis Bio shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is ANIK or ANVS more profitable? Annovis Bio has a net margin of 0.00% compared to Anika Therapeutics' net margin of -41.28%. Anika Therapeutics' return on equity of -7.22% beat Annovis Bio's return on equity.Company Net Margins Return on Equity Return on Assets Anika Therapeutics-41.28% -7.22% -5.64% Annovis Bio N/A -300.56%-193.50% Which has stronger valuation & earnings, ANIK or ANVS? Annovis Bio has lower revenue, but higher earnings than Anika Therapeutics. Anika Therapeutics is trading at a lower price-to-earnings ratio than Annovis Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnika Therapeutics$119.91M1.33-$56.38M-$3.88-2.87Annovis BioN/AN/A-$24.59M-$2.16-1.25 SummaryAnnovis Bio beats Anika Therapeutics on 8 of the 15 factors compared between the two stocks. Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANIK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANIK vs. The Competition Export to ExcelMetricAnika TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$159.89M$2.92B$5.56B$9.30BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-2.8720.3528.6119.64Price / Sales1.33304.32437.49188.30Price / Cash120.8843.1536.0257.93Price / Book1.067.718.185.63Net Income-$56.38M-$55.11M$3.23B$257.73M7 Day Performance-0.04%0.68%-0.25%0.07%1 Month Performance0.23%8.22%5.40%8.32%1 Year Performance-61.00%-2.64%26.35%13.78% Anika Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANIKAnika Therapeutics4.29 of 5 stars$11.14+1.2%$20.00+79.6%-60.1%$159.89M$119.91M-2.87300ANVSAnnovis Bio1.5568 of 5 stars$2.39+1.3%$18.00+653.1%-78.6%$46.57MN/A-1.113CERSCerus2.6209 of 5 stars$1.45-5.8%$3.50+141.4%-40.0%$277.18M$180.27M-14.50290Positive NewsOSUROraSure Technologies2.5146 of 5 stars$3.05-1.0%$3.00-1.6%-27.7%$228.14M$185.83M-7.26840UTMDUtah Medical Products2.2264 of 5 stars$57.19-2.1%N/A-18.8%$185.87M$40.90M15.13180WSTWest Pharmaceutical Services4.7896 of 5 stars$221.49-0.3%$320.00+44.5%-31.0%$15.91B$2.90B34.7710,600Positive NewsCOOCooper Companies3.2365 of 5 stars$73.290.0%$99.70+36.0%-18.6%$14.66B$3.90B35.5816,000Analyst ForecastHigh Trading VolumeALGNAlign Technology4.8423 of 5 stars$193.83-1.5%$241.25+24.5%-19.8%$14.05B$3.98B35.3120,945Positive NewsMMSIMerit Medical Systems4.2181 of 5 stars$91.12-2.6%$109.11+19.7%+9.3%$5.39B$1.36B44.677,400Positive NewsHAEHaemonetics4.886 of 5 stars$75.00-2.4%$96.80+29.1%-17.3%$3.60B$1.36B22.663,023Analyst RevisionICUIICU Medical4.3451 of 5 stars$129.71-4.2%$192.67+48.5%+0.6%$3.19B$2.38B-33.8715,000Positive News Related Companies and Tools Related Companies Annovis Bio Alternatives Cerus Alternatives OraSure Technologies Alternatives Utah Medical Products Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives Haemonetics Alternatives ICU Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANIK) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
